Embla

Denmark-based Embla provides virtual weight loss services via online consultations, coaching, and medication management. The company offers its services online via its app, which allows for virtual consultations with doctors, nurses, and coaches, who help users make lifestyle changes to help them lose weight. The app additionally includes access to community boards, educational material, recipes, and tracking functions for sleep, diet, and mental status. For users with body mass indices (BMI) over 30, the company prescribes weight loss medication, after completing a full background screening to exclude users who are pregnant and/or are addicted to alcohol or drugs. Once the weight loss medication is prescribed, users can collect their medication from local pharmacies. 

The company operates on a subscription basis, charging users GBP 34.50 per month for its basic weight loss program, GBP 45 per month for its limited medication-assisted weight loss program, and GBP 249 for its full medication-assisted weight loss program. The company operates across both Denmark and the UK.

Funding and financials

In August 2023, the company raised EUR 10 million (USD 10.9 million) in a Series A funding round co-led by Seed Capital and Inovo VC, along with participation from other venture capital firms. The raised funds were set aside to roll out its app in the UK, add AI-based features to help provide customized treatments, and hire 20–30 staff in 2024. The funds were to also be used to begin planning the company’s expansion into the US.